|
||
Tusybron Uses |
||
Tusybron is a cough suppressant with a predominantly peripheral action that has been used for non-productive cough
Dosing regimen of Oxo is individual. Daily dose of 200-800 mg, the multiplicity of application 2 times / day. For patients with impaired renal function (creatinine clearance 20-50 ml / min), the first dose is 200 mg, then 100 mg every 24 hours. When CC is less than 20 ml / min, the first dose is 200 mg, then 100 mg every 48 hours.
Simultaneous administration of Oxo with:
Digestive system: nausea, vomiting, diarrhea, abdominal pain and cramps, appetite loss, dry mouth, flatulence, gastrointestinal dysfunction, constipation; rarely - liver damage, liver necrosis, jaundice, hepatitis, intestinal perforation, pseudomembranous colitis, bleeding from the gastrointestinal tract, disorders of the oral mucosa, heartburn, elevated liver enzymes, including GGT and LDH, increased serum bilirubin.
CNS and peripheral nervous system: insomnia, dizziness, fatigue, drowsiness, nervousness; rarely - convulsions, anxiety, cognitive changes, depression, abnormal dreams, euphoria, hallucinations, paresthesia, syncope, tremor, confusion, nystagmus, suicidal thoughts or attempts, disorientation, psychotic reactions, paranoia, phobia, agitation, aggressiveness, emotional instability, peripheral neuropathy, ataxia, incoordination, exacerbation of extrapyramidal disorders, speech disorder.
Allergic reactions: skin rash, itching, rarely - angioedema, urticaria, vasculitis, allergic pneumonitis, anaphylactic shock, erythema multiforme, Stevens-Johnson syndrome, erythema nodosum, exfoliative dermatitis, toxic epidermal necrolysis, conjunctivitis.
Sexual system: an itch on the external genitalia in women, vaginitis, vaginal discharge; rare - burning, irritation, pain and rash in the genital area of women, dysmenorrhea, menorrhagia, metrorrhagia, vaginal candidiasis.
Cardiovascular system: rarely - heart failure, edema, hypertension, hypotension, palpitation, vasodilatation, cerebral thrombosis, pulmonary edema, and tachycardia.
Urinary system: rarely - dysuria, urinary frequency, urinary retention, anuria, polyuria formation of kidney stones, kidney failure, nephritis, hematuria, albuminuria, candiduria.
Musculoskeletal system: rarely - arthralgia, myalgia, tendonitis, muscle weakness, exacerbation of myasthenia gravis.
Metabolism: rarely - thirst, weight loss, hyper- or hypoglycemia (especially in patients with diabetes mellitus receiving insulin or oral hypoglycemic agents), acidosis, increase in serum triglycerides, cholesterol, potassium.
Respiratory system: rarely - cough, runny nose, respiratory failure, dyspnea, bronchospasm, stridor.
Sensory organs: rarely - hearing loss, tinnit, diplopia, nystagmus, impaired clarity of vision, disturbances of taste, smell, photophobia.
Dermatological reactions: rarely - photosensitivity, hyperpigmentation, vesicle-bullous eruption.
Hematopoietic system: rarely - anemia, hemorrhage, pancytopenia, agranulocytosis, leukopenia, reversible suppression of bone marrow hematopoiesis, thrombocytopenia, thrombocytopenic purpura, petechiae, ecchymosis, increased prothrombin time.
Other: chest pain, sore throat, fever, body aches, rarely - fatigue, chills, malaise, epistaxis, increased sweating.
* you are allergic to any ingredient in Dextromethorphan/Guaifenesin
* you have taken furazolidone or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days
* you are taking a selective serotonin reuptake inhibitor (SSRI) (eg, fluoxetine)
Oxolamine in Paraguay.
List of Tusybron substitutes (brand and generic names) | Sort by popularity |
Unit description / dosage (Manufacturer) | Price, USD |
Oxola (Taiwan) | |
Oxola 100 mg x 100 x 10's | |
Oxolam (Venezuela) | |
Oxolamina Andromaco (Chile) | |
Oxolamina Flupal (Venezuela) | |
Oxolamina Mintlab (Chile) | |
Oxolamina Proula (Venezuela) | |
Oxolamina Spefar (Venezuela) | |
Oxolamina Valmor (Venezuela) | |
Oxolamina Vitae (Mexico) | |
Oxolamine (Chile, Greece, Turkey, Venezuela) | |
Oxolavin compuesto (Venezuela) | |
Oxolev | |
Oxolev A | |
Oxomar (Mexico) | |
Oxomifer (Mexico) | |
Oxoquin (Mexico) | |
Oxotil (Venezuela) | |
Oxotus (Mexico) | |
Pecto BB (Paraguay) | |
Perbrons (Turkey) | |
Perebron (Chile, Greece, Turkey, Venezuela) | |
Syrup; Oral; Oxolamine Citrate 28 mg / 5 ml (Angelini) | |
Syrup; Oral; Oxolamine Phosphate 50 mg / 5 ml (Angelini) | |
Respibron (Chile, Peru) | |
Syrup; Oral; Oxolamine Citrate 28 mg / 5 ml (Andromaco) | |
Syrup; Oral; Oxolamine Phosphate 50 mg / 5 ml (Andromaco) | |
Sekodin (Turkey) | |
Subitol (Turkey) | |
Symphocal (Israel) | |
Syrup; Oral; Oxolamine Citrate 1% (Teva) | |
Symphocal Honey and Lemon Flavour | |
Syrup; Oral; Oxolamine Citrate 1% | |
Symphocal Raspberry Flavour | |
Syrup; Oral; Oxolamine Citrate 1% | |
Teratos (Chile) | |
Syrup; Oral; Oxolamine 28 mg / 5 ml (Konsuma) | |
Syrup; Oral; Oxolamine 50 mg / 5 ml (Konsuma) | |
Tosalbron (Peru) | |
Tosalbron Adulto (Peru) | |
Toxal (Mexico) | |
Toxolen (Venezuela) | |
Tukson (Mexico) | |
Tulox (Chile) | |
Tusebron (Turkey) | |
Tusol (Mexico) | |
Tussibron (Italy) | |
Zeco (Taiwan) | |
Zeco 100 mg | |
See 104 substitutes for Tusybron |
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|